Pfizer Inc. (PFE) vs Constellation Brands, Inc. (STZ)
A side-by-side comparison of Pfizer Inc. and Constellation Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: PFE is classified in Healthcare; STZ is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
PFE
Pfizer Inc.
$25.25HealthcareDelayed quote: Jul 28, 2026, 4:02 PM EDT
STZ
Constellation Brands, Inc.
$132.02Consumer DefensiveDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — PFE vs STZ
growth of $100 · dividends reinvested · last 30yPFE +562.5%STZ +4736.5%STZ compounded faster
Log scale — wide-divergence pair
PFE STZ
PFE vs STZ: by the numbers
- •PFE is the larger company ($143.91B vs $22.55B market cap).
- •STZ trades at the lower trailing earnings multiple (12.38 vs 18.83 P/E), one valuation lens rather than an overall verdict.
- •STZ converts more revenue to profit (20.14% vs 11.83% net margin).
- •PFE grew revenue faster over the past five years (8.22% vs 0.86% CAGR).
- •PFE pays the higher dividend yield (6.97% vs 3.15%).
Metrics side by side
Valuation
| Metric | PFE | STZ |
|---|---|---|
| P/E ratio | 18.83 | 12.38 |
| Forward P/E | 8.38 | 11.14 |
| P/S ratio | 2.23 | 2.47 |
| P/B ratio | 1.57 | 2.71 |
| EV / EBITDA | 9.72 | 9.87 |
| FCF yield | 6.71% | 8.20% |
Profitability
| Metric | PFE | STZ |
|---|---|---|
| Gross margin | 69.35% | 52.62% |
| Operating margin | 23.45% | 32.14% |
| Net margin | 11.83% | 20.14% |
| ROE | 8.31% | 22.10% |
| ROIC | 8.84% | 10.48% |
Dividends
| Metric | PFE | STZ |
|---|---|---|
| Dividend yield | 6.97% | 3.15% |
| Payout ratio | 126.47% | 42.52% |
Growth (annualized)
| Metric | PFE | STZ |
|---|---|---|
| Revenue CAGR (5Y) | 8.22% | 0.86% |
| EPS CAGR (5Y) | -3.78% | -1.59% |
| FCF CAGR (5Y) | -3.79% | -1.73% |
| Total return CAGR (5Y) | -5.21% | -8.34% |
Frequently asked
- Which has the lower trailing P/E, PFE or STZ?
- STZ has the lower trailing P/E: PFE trades at 18.83 and STZ at 12.38. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, PFE or STZ?
- Over the past five years, PFE grew revenue faster — PFE at a 8.22% CAGR versus STZ at 0.86%.
- Does PFE or STZ pay a bigger dividend?
- PFE yields 6.97% and STZ yields 3.15% based on trailing dividends and the latest price.
- Is PFE or STZ more profitable?
- STZ runs the higher net margin — PFE at 11.83% versus STZ at 20.14%.
- How have PFE and STZ total returns compared?
- Over the past 10 years, PFE delivered 1.55% and STZ delivered -0.43% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Pfizer P/E ratioConstellation Brands P/E ratioPfizer dividend yieldConstellation Brands dividend yieldPfizer ROEConstellation Brands ROEPfizer operating marginConstellation Brands operating marginPfizer revenue growthConstellation Brands revenue growthPfizer free cash flowConstellation Brands free cash flow
Pfizer & Constellation Brands appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.